Popular Men’s Prostate Pill Linked To Blinding Risk

Millions of men take tadalafil every day for prostate problems or erectile dysfunction, and a new study says that same pill might be quietly raising their risk of glaucoma.

Quick Take

A study of nearly 74,000 men found tadalafil users had a 22% higher risk of glaucoma over five years than non-users.
Ocular hypertension risk rose 32%, and primary open-angle glaucoma risk rose 33% among tadalafil users.
The study only shows a link, not proof that tadalafil causes glaucoma.
Other research suggests the drug class may actually protect eye health or have no effect on eye pressure at all.

What The New Research Actually Found

Researchers pulled records from the TriNetX database, covering men age 40 and older with lower urinary tract symptoms treated between 2012 and 2022. They matched 36,927 tadalafil users against the same number of similar men who did not take the drug. Over five years, the tadalafil group showed a clear pattern of eye trouble that the comparison group did not share.

The glaucoma risk jumped 22% in tadalafil users compared to men who never took the drug. Ocular hypertension, a condition where pressure builds inside the eye, rose 32%. Primary open-angle glaucoma, the most common form of the disease, climbed 33%. Doctors also saw more men starting glaucoma treatment after taking tadalafil for their urinary symptoms.

Why Doctors Are Not Sounding The Alarm Yet

The study’s own authors point out a major limit. This was an observational study, meaning it tracked what happened to real patients over time. It did not run a controlled experiment where some men got tadalafil and others got a fake pill. That design cannot prove the drug causes glaucoma, only that the two show up together more often than expected.

Review of Optometry reported that the researchers themselves doubted a direct chemical cause. They said the glaucoma link probably does not come from tadalafil changing the fluid pressure inside the eye directly. Something else may be driving the connection, like shared risk factors between men who need the drug and men who develop eye disease.

The Case On The Other Side

A separate review of the evidence reached a very different conclusion. It found that phosphodiesterase type 5 inhibitors, the drug family that includes tadalafil and Viagra, show a neutral effect on eye pressure overall. That same review noted the drugs consistently boost blood flow to the choroid, the layer behind the retina, and suggested a possible protective link against glaucoma rather than a harmful one.

Another study went further, finding that men who used PDE5 inhibitors long-term actually had a lower rate of glaucoma suspect diagnoses and open-angle glaucoma compared to non-users. The authors called this a “potential protective association” but said it needs confirmation in future prospective studies before anyone treats it as settled science.

Long-term use of tadalafil requires caution regarding the risk of glaucoma, and regular eye examinations are essential. pic.twitter.com/p0N0A7nyjf

— Alex Fong (@alex_fong45894) August 30, 2026

A 2021 review summed up the broader confusion well. It said there simply are not enough randomized trials to prove whether these drugs truly raise eye pressure and cause glaucoma over time, even though visual side effects like light sensitivity and color changes are well documented in a smaller share of users.

What Men Taking These Drugs Should Do

Nobody is telling men to throw away their prescriptions based on one observational study. But the honest answer here is that science does not yet have a final verdict. One large study points toward higher glaucoma risk. Other reviews point toward a neutral or even protective effect. That gap is exactly why doctors recommend routine eye pressure checks for men on long-term tadalafil, especially those with family history of glaucoma or other risk factors already in play.

A cheap eye exam beats guessing. Men weighing quality of life against a small, unproven risk deserve real data, not headlines built to scare or reassure. Until a randomized trial settles the question, informed choice paired with regular checkups is the responsible path, not panic and not blind trust in a single study’s numbers.